PMID- 28245636 OWN - NLM STAT- MEDLINE DCOM- 20170420 LR - 20181113 IS - 1422-0067 (Electronic) IS - 1422-0067 (Linking) VI - 18 IP - 3 DP - 2017 Feb 26 TI - A Comparison of the Effects of Benzalkonium Chloride on Ocular Surfaces between C57BL/6 and BALB/c Mice. LID - 10.3390/ijms18030509 [doi] LID - 509 AB - Models of benzalkonium chloride (BAC)-induced ocular disruption have been created and are widely used in various animals. This study aimed to compare the effects of BAC on the ocular surfaces of C57BL/6 and BALB/c mice. C57BL/6 and BALB/c mice were treated separately with BAC eye-drops at different concentrations. Eyes were evaluated by scoring epithelial disruption, corneal opacity and neovascularization in vivo, and by histological assays with hematoxylin/eosin (H/E) and periodic acid-Schiff stainings and by determining the expression of inflammatory factors in vitro on Days 7 and 14. The in vivo corneal epithelial disruption, corneal edema/opacity and neovascularization, which were in accordance with the results of the H/E staining and peaked at Day 7, were observed in a dose-dependent manner in the BAC-treated mice, with more severe signs in the C57BL/6 mice than the BALB/c mice. The loss of conjunctival goblet cells in the conjunctivas and the increasing expression of monocyte chemoattractant protein 1 (MCP-1), growth-regulated protein alpha (GROa) and macrophage inflammatory protein-1 alpha (MIP-1a) in the corneas were found in a dose-dependent manner in both strains of mice. Topical application of BAC can dramatically disrupt the ocular surfaces of C57BL/6 and BALB/c mice, and the disruptions were much more severe in the C57BL/6 mice that received high doses of BAC. FAU - Yang, Qian AU - Yang Q AD - Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China. muyangmay@126.com. FAU - Zhang, Yafang AU - Zhang Y AD - Department of Ophthalmology, Hubei University of Science and Technology, Xianning 437100, China. zhangyafang709@163.com. FAU - Liu, Xiuping AU - Liu X AD - Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China. LXP__2171@126.com. FAU - Wang, Nan AU - Wang N AD - Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China. yankewangnan@126.com. FAU - Song, Zhenyu AU - Song Z AD - Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China. songzhenyu08@sina.com. FAU - Wu, Kaili AU - Wu K AD - Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China. wukaili@mail.sysu.edu.cn. AD - Department of Ophthalmology, Hubei University of Science and Technology, Xianning 437100, China. wukaili@mail.sysu.edu.cn. LA - eng PT - Journal Article DEP - 20170226 PL - Switzerland TA - Int J Mol Sci JT - International journal of molecular sciences JID - 101092791 RN - 0 (Anti-Infective Agents, Local) RN - 0 (Benzalkonium Compounds) RN - 0 (Inflammation Mediators) RN - 0 (Ophthalmic Solutions) SB - IM MH - Animals MH - Anti-Infective Agents, Local/administration & dosage/*pharmacology MH - Benzalkonium Compounds/administration & dosage/*pharmacology MH - Conjunctiva/drug effects/metabolism/pathology MH - Cornea/drug effects/metabolism/pathology MH - Disease Models, Animal MH - Female MH - Inflammation Mediators/metabolism MH - Mice MH - Mice, Inbred BALB C MH - Mice, Inbred C57BL MH - Ophthalmic Solutions/administration & dosage/*pharmacology MH - Xerophthalmia/drug therapy/metabolism/pathology PMC - PMC5372525 OTO - NOTNLM OT - BALB/c OT - C57BL/6 OT - benzalkonium chloride OT - conjunctiva OT - cornea OT - mouse COIS- The authors declare no conflict of interest. EDAT- 2017/03/02 06:00 MHDA- 2017/04/21 06:00 PMCR- 2017/03/01 CRDT- 2017/03/02 06:00 PHST- 2017/01/01 00:00 [received] PHST- 2017/02/13 00:00 [revised] PHST- 2017/02/23 00:00 [accepted] PHST- 2017/03/02 06:00 [entrez] PHST- 2017/03/02 06:00 [pubmed] PHST- 2017/04/21 06:00 [medline] PHST- 2017/03/01 00:00 [pmc-release] AID - ijms18030509 [pii] AID - ijms-18-00509 [pii] AID - 10.3390/ijms18030509 [doi] PST - epublish SO - Int J Mol Sci. 2017 Feb 26;18(3):509. doi: 10.3390/ijms18030509.